Nuance Healthcare ’s Post

Excited about our upcoming Health Innovators Collaborative (HIC) meeting on February 27th! Curious about what we'll be diving into or considering registering? Reach out, and let's chat! #PINCAI #dataempowerment #leveragingdata

🩺 𝐏𝐢𝐨𝐧𝐞𝐞𝐫𝐢𝐧𝐠 𝐀𝐈 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞: 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐃𝐨𝐦𝐚𝐢𝐧-𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐀𝐈 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝐎𝐩𝐞𝐧 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 As the enterprise AI landscape evolves, it's evident that businesses require solutions tailored to their specific needs. Yet, defining these AI needs and identifying the right use cases remains a struggle for many. At DAVINCE.AI, we've teamed up with innovation accelerators like acitoflux to drive sector-specific advancements. Our goal is clear: to foster industry-wide collaboration that sharpens the focus of enterprise AI applications, beginning with Health Tech. 🚀 Ready to become a 'Pioneer in Health Tech'? 📅 Mark your calendar for June 27th, and join me at Pioneers of Health Tech for an expert session with Peter Aulbach from Siemens Healthineers. Don’t miss this chance to be at the cutting edge of digital health innovation! 🔗 P.S.: Find the registration link in the comments below.

🎲 Are you in Vegas at HFMA? 🎲 What are you doing Tuesday at 9:50 a.m. PT? The correct answer is attending the Johns Hopkins Medicine and AKASA session on generative AI and the revenue cycle in Mandalay F. Lakmini Kidder, Vice President of Revenue Cycle Management at Johns Hopkins Medicine, and Malinka Walaliyadde, CEO of AKASA, will share everything healthcare leaders need to know about this innovative technology and how revenue cycles are taking advantage of it. You’ll learn about: 🤖 The evolution of GenAI 🧐 How leading health systems are evaluating this technology in the revenue cycle 📈 How GenAI can drive innovation and improve performance in prior authorization and beyond See you there!

Starting soon! Come see our CEO J (Ramesh) Sairamesh along with a panel of other experts in AI and healthcare, highlighting how healthcare and life sciences organizations are seeing transformational change!

Excited to be back on the road after the summer break next week! 🌍🚆✈️🚗 First pit stop: the beautiful city of Paris to also recharge eyes and soul. 🗼 Then, I'll be heading to the Intelligent Health Conference in Basel, where cutting-edge advancements in healthcare technology will be in the spotlight.💡 Next up: NYC and Boston for more insightful meetings and discussions with industry leaders. Looking forward to connecting with fellow professionals, sharing insights, and exploring the latest trends in healthcare innovation! Stay tuned for updates, and if you're interested in learning more about our AI-driven approach to the Probability of Technical and Regulatory Success in #drugdevelopment, please reach out. 🤝💊🤖 #Intelligent Health AI #Intelligencia.ai

At the side event on artificial intelligence and digital health during the 3rd #G20Brazil health working group meeting, our Chief Technology Officer @Marta Fernández Suárez delivered a statement on the revolutionizing potential of AI. 🤖 To make sure these technologies benefit everyone, FIND is calling for the G20 to consider these measures: 1️⃣Develop national data governance frameworks and make high-quality datasets available for key health-related use-cases in LMICs. 2️⃣Address regulatory barriers with evidence generation frameworks to evaluate technology performance. 3️⃣Support development, evaluation and scale-up of multi-disease, decision support algorithms for integrated screening and diagnostics services. 4️⃣Enable a ground-up, connected and interoperable diagnostic data ecosystem for effective surveillance, outbreak prediction and response. Read the full statement here: https://lnkd.in/ecjX7MiC

Last week, California Life Sciences hosted our third annual MedTech Day, in partnership with AdvaMed. More than 30 executives met with 20 state lawmakers from Assembly and Senate Health Committees to talk about California's dynamic MedTech industry. Following the meetings, we convened a panel of industry leaders to discuss critical policy issues impacting artificial intelligence (Al) regulation and patient access. Follow the link below to learn how CLS member companies are charting the AI revolution. How CLS members are charting the AI revolution (https://bit.ly/3UItdT1)

Just before the winter holidays, Elisabeth Kasilingam, EPF Vice President, attended the roundtable discussion that marked the official launch of the European Virtual Human Twins (VHT) Initiative in Barcelona. The event brought together high level representatives of the European Commission, the Catalan, and the Spanish government, as well as diverse stakeholders (academia, patient organisatons, healthcare providers, industry).     The European Virtual Human Twins Initiative is a flagship project of the European Commission to foster and accelerate the development of integrated, validated digital representations of the human body. Voicing out the patient perspective, Elisabeth Kasilingam underlined that for patients trust is at the core of AI solutions uptake and acceptance, therefore the same applies to the VHT. In order to ensure a long-term sustainable trust in the ecosystem, it is key to invest on transparency of processes that inform outcomes and to anticipate and eventually mitigate risks. Active patient engagement throughout the AI solution lifecycle ensures a realistic assessment, enhancing well-being, accessibility, and alignment with patient needs.

Only one week left to the Intelligent Health AI 2023! Let's meet in Basel, Switzerland, and discuss the future of AI in Healthcare. To book a meeting with us, drop an email at contact@meddare.com #IntelligentHealth #SaveLivesWithAI

The dust has settled, and somehow RSNA 2023 is in the books. This was by far our most successful conference to date, and we were energized by the reception we received. Some highlights from us:   A week ago tonight, we cohosted an intimate event with our partners at Centaur Labs for our customers and friends. This was an opportunity to say thank you to our valued community with some great food, drinks, and company. If you attended and helped to make it so successful, thank you!   We also thought we'd take a moment to share some other insights and developments that we saw from the world of radiology AI that are shaping our future.   AI: The New Mainstream in Radiology. AI's integration into daily practices isn't just a pipedream anymore, it is accelerating and is being used to enhance diagnostic precision and patient care.   Foundational Models: The First Movers Hit the Market. The opening day of RSNA saw HOPPR launch "Grace", a multi-modal foundation model for medical imaging, with huge potential! We are proud to have played a role in providing the staggering quantity of data needed to train Grace (over a petabyte). As our our CEO Joshua Miller Miller wrote about in a recent opinion piece, we've been seeing more and more requests for foundational model-level datasets.    The Persistent Challenge: Access to Large Datasets. Despite the advancements, one challenge remains: the need for quick and efficient access to large, unbiased datasets. The richness of data is crucial for the effectiveness of AI, yet accessing these vast datasets remains a hurdle for many in the field (spoiler, this is where we step in). Early Access to Our Subscription Service: An Invitation. Following promising feedback from our poll in last month's newsletter, we are launching early access to our subscription service. This initiative is designed to empower developers with direct access to our tools and datasets, streamlining workflows and expanding capabilities while giving you economies of scale. We 'soft launched' this model with a special offer at RSNA and we were so encouraged by the uptake that we thought we'd extend it. So if instant access to huge datasets via a subscription model sounds like it makes sense for you, book a meeting with our team and enjoy some early adopter savings! Until next time McCormick Place! #medicalimaging #rsna2023 #aiinmedicine | Ouwen Huang, PhD | Rod B. Greco | Lucas Alves